SWAV ShockWave Medical
- 329.840
- -0.350-0.11%
- 326.000
- -3.840-1.16%
ShockWave Medical News
CL King: Downgraded Shockwave Medical (SWAV.US) rating from buy to neutral.
Leerink Partners: Downgraded Shockwave Medical (SWAV.US) rating from superior to market to consistent market rating, target price adjusted from $361.00 to $335.00.
Leerink Partners Downgrades Shockwave Medical to Market Perform, Lowers Price Target to $335
CL King Downgrades CL King to Neutral From Buy, Cuts Price Target to $335 From $368
Analysts Have Conflicting Sentiments on These Healthcare Companies: Deciphera Pharmaceuticals (DCPH) and Shockwave Medical (SWAV)
Damo: The Shockwave Medical (SWAV.US) rating was lowered from an increase in holdings to a wait-and-see rating, and the target price was adjusted from $285.00 to $335.00.
Shockwave Medical Analyst Ratings
Morgan Stanley Downgrades Shockwave Medical to Equal-Weight, Raises Price Target to $335
Shockwave Medical Analyst Ratings
Canaccord Genuity Downgrades Shockwave Medical to Hold, Raises Price Target to $335
Analysts Offer Insights on Healthcare Companies: Immunic (IMUX) and Shockwave Medical (SWAV)
Shockwave Medical Analyst Ratings
Shockwave Medical Analyst Ratings
Analysts Are Bullish on These Healthcare Stocks: Shockwave Medical (SWAV), Veeva Systems (VEEV)
Shockwave Medical Analyst Ratings
Analysts Offer Insights on Healthcare Companies: Merck & Company (MRK), Shockwave Medical (SWAV) and Korro Bio (KRRO)
Shockwave Medical (SWAV) Gets a Buy From Bank of America Securities
Wells Fargo Reaffirms Their Hold Rating on Shockwave Medical (SWAV)
Analysts Offer Insights on Healthcare Companies: Jazz Pharmaceuticals (JAZZ), Shockwave Medical (SWAV) and Healthequity (HQY)
UBS Raises Price Target on ShockWave Medical to $250 From $228, Maintains Neutral Rating
Analysis
Price Target
No Data
